TCT 2021 | Learnings of COVID-19 on transplant and cellular therapies

Name: Learnings of COVID-19 on transplant and cellular therapies
Uploaded: 2021-02-05T00:00:00Z
Duration: 1 min 38 s
Description: Katie Maurer, MD, PhD, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, outlines learnings from the ongoing COVID-19 pandemic in the management of patients undergoing transplant and treatment with cellular therapies. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

Katie Maurer • 5 Feb 2021

TCT 2021

General

Katie Maurer, MD, PhD, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, outlines learnings from the ongoing COVID-19 pandemic in the management of patients undergoing transplant and treatment with cellular therapies. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.